The Application of [⁶⁸Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models

Figure 1

Characteristic of [⁶⁸Ga]FAPI-04, the quinoline-based FAP-specific inhibitor. (a) Molecular formula of [⁶⁸Ga]FAPI-04; (b) comparison of FAP expression between Pan-cancer and normal tissue. Note: data from TCGA and GTEx; (c) comparison of FAP expression between PDAC and normal tissue; and (d) FAP Expression in different stages of PDAC.

(a)

(b)

(c)

(d)